About Lisa Nachtigall, MD

No link text selected.

Dr. Lisa Nachtigall is the Director of the Neuroendocrine Clinical Center at Massachusetts General Hospital and an Associate Professor of Medicine at Harvard Medical School. In addition, she is the director of MGH International Education Programs for the MGH Endocrine Division, and of  the MGH/Harvard Medical School advanced clerkship in Clinical Neuroendocrinology. Her primary clinical focus is in pituitary disorders.  She has extensive clinical experience in all aspect of pituitary care, particularly acromegaly, and has published clinical research papers in this area. She has received awards for teaching and clinical investigation.

Departments, Centers, & Programs:

Clinical Interests:

Treats:

Locations

Neuroendocrine and Pituitary Tumor Clinical Center
55 Fruit Street
Cox 140
Boston, MA 02114-2696
Phone: 617-726-7948
Fax: 617-726-1241

Medical Education

  • MD, New York University School of Medicine
  • Residency, New York University School of Medicine
  • Fellowship, Massachusetts General Hospital

American Board Certifications

  • Internal Medicine, American Board of Internal Medicine
  • Endocrinology, Diabetes and Metabolism, American Board of Internal Medicine

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


Research

My study of how 100 patients with acromegaly came to diagnosis targeted education on this rare disease to professionals who most likely encounter it. I investigated a long acting somatostatin analog with a novel delivery system. I have contributed to several reviews on acromegaly and hyperprolactinemia and edited chapters on these topics. I have created an acromegaly database, including longitudinal data in over 350 patients, which will improve clinical practice strategies and serve as a resource for clinical investigation and as a model for database construction. I received an investigator initiated award to study long term treatment of acromegaly with somatostatin analogs.

Publications